Dermatomyositis and lupus may share symptoms in some cases. Here's what you need to know about these autoimmune conditions.
Dazukibart, a type I interferon inhibitor, reduced dermatomyositis disease severity while maintaining a well-tolerated safety ...
Achievement of cancer remission was associated with dermatomyositis complete clinical response among patients with cancer-associated DM.
Dermatomyositis is a rare inflammatory disease characterized by muscle weakness and skin rash. The exact cause is unknown, ...
On top of that, imagine dealing with a red, scaly rash creeping across your face. This might be dermatomyositis, a rare illness that brings both muscle weakness and skin problems together.
Dermatomyositis (DM) is a chronic autoimmune disease characterized by inflammatory myopathy and distinctive skin ...
Opens in a new tab or window An investigational monoclonal antibody targeting interferon beta (IFNβ) led to rapid and pronounced reductions in disease activity in adults with dermatomyositis ...
A new study published in The Lancet journal showed that dermatomyositis disease activity is reduced by Dazukibart which ...
Despite the recent rise in herbal supplement use, research suggests certain supplements may pose risks for patients with autoimmune diseases.
Dazukibart, an anti–interferon beta monoclonal antibody, showed potential in reducing dermatomyositis symptoms, with significant improvements in skin disease activity.